Brief: Pacbio posts Preliminary Q1 2025 Revenue And Reiterates 2025 Revenue Guidance
09/04/2025 14:17
April 9 (Reuters) - Pacific Biosciences of California Inc PACB.O: PACBIO ANNOUNCES PRELIMINARY FIRST QUARTER 2025 REVENUE AND REITERATES 2025 REVENUE GUIDANCE OF $155 MILLION TO $170 MILLION PACIFIC BIOSCIENCES OF CALIFORNIA: GIVEN UNCERTAINTY IN ACADEMIC, NIH FUNDING & NEW TARIFFS, REDUCING SPENDING TO ACHIEVE POSITIVE CASH FLOW BY 2027 Source text: ID:nGNX5DZtbp Further company coverage: PACB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacific Biosciences of California
See all newsBrief: Pacbio And Verily Health Announce Multi-Year Strategic Collaboration
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30 - Earnings Summary
Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure
Brief: Pacific Biosciences of California Q2 EPS USD -0.14
Pacific Biosciences of California Inc expected to post a loss of 13 cents a share - Earnings Preview